Additionally, Thompson et al. demonstrated the role of NIS dimerization for its movement to the plasma membrane, suggesting new mechanisms to be considered in treating patients with RAI-refractory thyroid cancer in the future 224. This evidence concerns the gene SLC5A5 and thyroid cancer.